Avanir Pharmaceuticals Inc. Cl A (AVNR) News Nov 20, 2014,

New Post Public Reply Private Reply Replies (0) Message Board

Nov 20, 2014 at 7:01 PM

Avanir Pharmaceuticals Inc. Cl A (AVNR) News Nov 20, 2014, 5:14 p.m.
MarketWatch News on AVNR
6 stocks to watch 3:06 p.m. Nov. 5, 2014 - The Trading Deck
U.S. markets break out, confirm primary uptrend 11:12 a.m. Nov. 3, 2014 - Michael Ashbaugh
6 stocks to watch 2:10 p.m. Oct. 22, 2014 - The Trading Deck
5 stocks to watch 1:37 p.m. Sept. 24, 2014 - The Trading Deck
4 stocks to watch 2:47 p.m. Sept. 18, 2014 - The Trading Deck
5 companies that will benefit from ALS awareness 6:58 a.m. Aug. 22, 2014 - Jennifer Booton
U.S. stock futures cut rise after retail sales 7:53 a.m. Aug. 13, 2013 - Barbara Kollmeyer
Cree, Flowers Foods in focus Tuesday 7:42 a.m. Aug. 13, 2013 - Wallace Witkowski
Yum Brands shares drop on sour China sales 4:23 p.m. Aug. 12, 2013 - Wallace Witkowski
Avanir to promote Merck's diabetes drug Januvia 3:48 p.m. Aug. 12, 2013 - MarketWatch.com
Avanir shares rise after hours on license deal 5:29 p.m. July 2, 2013 - Wallace Witkowski
Avanir, OptiNose enter N. America licensing deal 4:27 p.m. July 2, 2013 - MarketWatch.com
7 gut checks before the stock market's opening bell 5:43 a.m. April 29, 2013 - Shawn Langlois
Avanir Pharmaceuticals shares down 3% 9:37 a.m. Nov. 17, 2010 - Nick Godt
Monday’s biggest gaining and declining stocks 4:25 p.m. Nov. 1, 2010 - Laura Mandaro
Avanir and Allergan lead drug stocks 12:55 p.m. Nov. 1, 2010 - Val Brickates Kennedy
Avanir leads drug stocks north 9:06 a.m. Nov. 1, 2010 - Val Brickates Kennedy
Rexahn, Avanir gain; Sequenom falls 12:32 p.m. April 7, 2010 - Val Brickates Kennedy
Avanir, Opexa gain ahead of presentations 2:16 p.m. April 6, 2010 - Val Brickates Kennedy
Avanir shares jump 10% in pre-market action 8:27 a.m. April 6, 2010 - Val Brickates Kennedy

Other News on AVNR
Biggest Movers in Healthcare Stocks Now – AVNR COV BMRN ALXN 1:00 p.m. Nov. 19, 2014 - InvestorPlace.com
Hottest Healthcare Stocks Now – CLDX AVNR AUXL AZN 6:15 a.m. Nov. 19, 2014 - InvestorPlace.com
Avanir Faces Regulatory Setback, AVP-825 Could Be Delayed - Analyst Blog 5:40 p.m. Nov. 10, 2014 - Zacks.com
Avanir Pharmaceuticals (AVNR) Stock Drops After FDA Provides New Drug Application Feedback 11:25 a.m. Nov. 7, 2014 - TheStreet.com
Will Avanir Pharmaceuticals (AVNR) Stock React Today to This Analyst Action? 8:52 a.m. Nov. 4, 2014 - TheStreet.com
Looking For My Next Triple In Biotech 1:26 p.m. Oct. 31, 2014 - Seeking Alpha
Perilous Reversal Stock: AVANIR Pharmaceuticals (AVNR) 10:19 a.m. Oct. 31, 2014 - TheStreet.com
Avanir Pharmaceuticals, Inc. (AVNR): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 8:00 a.m. Oct. 31, 2014 - Zacks.com
Trade-Ideas: AVANIR Pharmaceuticals (AVNR) Is Today's Post-Market Leader Stock 4:19 p.m. Oct. 30, 2014 - TheStreet.com
5 Stocks That Will See Huge Buying Friday on Russell 2000 Rebalance 7:48 a.m. Oct. 30, 2014 - 247WallSt.com
Hottest Healthcare Stocks Now – APTO AVNR CNC XRAY 8:45 a.m. Oct. 29, 2014 - InvestorPlace.com
Hottest Healthcare Stocks Now – LCI AVNR MWIV ABC 8:00 a.m. Oct. 27, 2014 - InvestorPlace.com
Genervon ALS drug shows encouraging results 8:27 a.m. Oct. 20, 2014 - Seeking Alpha
Biotech Stock Mailbag: Small-Cap Rebound, Avanir, Ohr, CytoSorbents 7:05 a.m. Oct. 17, 2014 - TheStreet.com
Intra-Cellular Therapies Reveals Top-line Data on ITI-007 - Analyst Blog 5:50 p.m. Oct. 16, 2014 - Zacks.com
Concert Pharmaceuticals Announces Positive CTP-354 Data - Analyst Blog 6:04 p.m. Oct. 15, 2014 - Zacks.com
Avanir (AVNR) Presents Detailed Phase II Data on AVP-923 - Analyst Blog 5:30 p.m. Oct. 14, 2014 - Zacks.com
Avanir presents AVP-923 Phase 2 data at neurology meeting 5:34 p.m. Oct. 13, 2014 - Seeking Alpha
Micro-Cap ETF And The Falling Greenback 4:28 p.m. Oct. 13, 2014 - Benzinga.com
Trade-Ideas: AVANIR Pharmaceuticals (AVNR) Is Today's Post-Market Leader Stock 4:17 p.m. Oct. 13, 2014 - TheStreet.com

Press Releases on AVNR
Avanir Pharmaceuticals Announces Preliminary Feedback from the FDA on AVP-825 for the Acute Treatment of Migraine 8:30 a.m. Nov. 7, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Announces Publication of Pivotal Phase III Results from AVP-825 Acute Migraine Study in the Journal "Headache" 3:01 p.m. Oct. 30, 2014 - PR Newswire - PRF
Pharma Stocks Technical Data - Allergan, Zoetis, Actavis, Avanir Pharma, and Mallinckrodt 7:40 a.m. Oct. 20, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals to Host Investor Briefing on October 15, 2014 3:15 p.m. Oct. 8, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Announces Data Presentations at the American Neurological Association's (ANA) 2014 Annual Meeting Including Results from the Phase II Trial for Treatment of Agitation in Patients with Alzheimer's Disease 7:30 a.m. Oct. 8, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares 8:15 a.m. Sept. 29, 2014 - PR Newswire - PRF
Acquisitions, Senior Level Promotions, Public Offering, and Drug Approvals - Research Reports on Acorda, Alexion, Envision, Lilly and Avanir 7:50 a.m. Sept. 29, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Announces Pricing of Public Offering of Common Stock 9:00 p.m. Sept. 23, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Announces Proposed Public Offering of Common Stock 3:45 p.m. Sept. 22, 2014 - PR Newswire - PRF
Positive Study Results, Market Activity, Acquisition Proposal, Earnings Schedules, and Collaboration - Research Reports on Avanir, Jazz, Alere, Intuitive Surgical and GSK 8:05 a.m. Sept. 18, 2014 - PR Newswire - PRF
Critical Alerts For Yahoo!, El Pollo Loco, Avanir Pharmaceuticals, General Electric and Ballard Power Systems Released By InvestorsObserver 8:31 a.m. Sept. 16, 2014 - PR Newswire - PRF
Reveal Insider Trading for Yahoo, Apple, Facebook, Avanir Pharmaceuticals, Tesla Motors, and Twitter 7:55 a.m. Sept. 16, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Announces Positive Phase II Trial Results for AVP-923 in Treatment of Agitation in Patients with Alzheimer's Disease 7:30 a.m. Sept. 15, 2014 - PR Newswire - PRF
Technical Snapshot on Pharma Stocks - Allergan, Akorn, Mallinckrodt, Mylan, and AVANIR Pharma 8:25 a.m. Sept. 8, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Conference 8:00 a.m. Sept. 2, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 8:00 a.m. Aug. 26, 2014 - PR Newswire - PRF
Technical Analysis on Pharma Equities -- Mylan, AVANIR Pharma, Horizon Pharma, VIVUS, and Auxilium Pharma 8:10 a.m. Aug. 6, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Reports Fiscal 2014 Third Quarter Financial and Business Update 3:01 p.m. Aug. 5, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Announces Date of Fiscal 2014 Third Quarter Financial Results and Conference Call 7:31 a.m. July 28, 2014 - GlobeNewswire
Avanir Pharmaceuticals Announces FDA Acceptance of IND for AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 8:15 a.m. July 21, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Accuray Finishes Key Deal, Resetting Financial Trajectory

Accuray Secures the Deal, But Is the Future Bright? Every now and then in the investing world, a company pulls off a maneuver that you wish you’d thought of first. Today, folks, it's Accuray's turn. They've just wrapped up a monstrous transaction with TCW – their primary lender and shareholder – that has them feeling optimistic about the road ahead. Bold Moves to...

Data Center Transformers on the Brink of a Boom

A Flash Look: Powering Up Data Centers Look, if you're thinking of sidestepping data center transformers as just another cog in the machine, think again. This market's set to balloon—doubling from $5.59 billion in 2026 to a jaw-dropping $10.72 billion by 2031. We're talking a chunky 13.9% CAGR. Not every bit of news grabs you by the lapels, but this one does. What’s...

FiEE Rockets to Profitability with 382% Revenue Surge

Big Moves in the Tech Jungle: FiEE's Comeback Let's chew the fat on FiEE, Inc., a company that's left its hardware-heavy past in the dust and grabbed the bull by the horns with fresh, AI-driven brand tech solutions. We're talking a whopping 382.1% revenue increase. Now, that's not chump change. From barely scraping $2 million last year to raking in $9.6 million just for...

Custom Upholstered Furniture: Comfort Built to Last

Rethinking Furniture Comfort: Not Just a Luxury Diving into the world of custom upholstered furniture with insights from Randy Marohn is like finding a cheat sheet for comfort. Seriously, it ain't just about plush cushions or slick fabrics—it's a bonafide science. Marohn, from Sans Furniture Inc. in good ol’ Hamburg, NY, unfolds a tale of intentional design and...

Noël Jolié's Cream Earns Spot on Oprah's List

The Powerhouse of Oprah's Seal of Approval Ever notice what happens when Oprah drops a nod towards any brand? It's like Midas touching everything gold. That's exactly the scenario with Noël Jolié, a Chicago-based luxury body care operation, hitting the jackpot by landing its Velours Silken Body Cream on Oprah's Favorite Things 2026. You can't buy this kind of press,...

Fitness Career Platform's Big Ramp Up Sparks Buzz

ISSA Career Connect Gains Industry Recognition In a world where finding that first job post-certification can be as brutal as a spin class in August, ISSA Career Connect seems to be offering a bit of a lifeline. This platform, already making some serious noise in the fitness industry, has just snagged a place as a finalist for App of the Year at the 2026 Beyond Activ...

Aluminum Fluoride Market to Hit $3.3B by 2031

Eye on the Aluminum Fluoride Surge Cracking open the numbers, the aluminum fluoride market is projected to swell from $2.48 billion in 2026 to a hefty $3.30 billion by 2031, trucking along at a CAGR of 5.9%. That's no small potatoes in the world of industrial materials. Scratch the surface, and you’ll see what's fueling this climb—think of it as a bellwether for...

Odessa Water Overbilling Lawsuit Surges Ahead

Full Steam Ahead for Odessa's Water Fight Odessa, a dust-blown Texas town, ain't giving up without a fight. The court just lit a fire under the efforts of 46,000 residents and businesses hollering about their water bills that seemed to skyrocket outta nowhere. This court ruling lets the class action against the City of Odessa and Performance Services—they're the folks...

Kentucky Power's Bold Plan to Boost Local Economy

Electricity, Economy, and Execution Kentucky Power just laid out plans that could massively swing the pendulum for eastern Kentucky's economic prospects. They've put filings on the table for the Kentucky Public Service Commission that, if approved, promise big economic benefits. We're talking about a potential infusion of $500 million through fixed-rate offsets and an...

Dana-Farber Integrates IconPCR for Precise cfDNA Sequencing

Innovating Precision in cfDNA Sequencing One day you're trudging along old paths, and the next, technology throws you a curveball that's too critical to ignore. That's the scene at Dana-Farber Cancer Institute with their latest lab upgrade. They've bent the knee to integrate n6's iconPCR system into their toolkit for liquid biopsy research—a move that's caught my...